下肢旁路术后外周动脉疾病患者的阿片类药物使用情况
该回顾性研究分析了2017年6月至2021年3月期间因跛行或静息痛接受下肢开放旁路术的3873例患者,评估术前阿片使用与术后30天持续使用的关系。结果显示,术前使用阿片者中61.3%在30天随访时仍在使用,而术前未使用者中亦有28.4%持续使用;术后阿片处方与持续使用强烈相关(aOR 10.83)。
要点
- 术前使用阿片者的术后30天持续使用率达61.3%,术前未使用者为28.4%。
- 术后阿片处方与持续使用强相关(aOR 10.83,95%CI 7.96-15.06)。
- 术前阿片使用也是持续使用的独立危险因素(aOR 3.23,95%CI 2.70-3.89)。
核心结论
- 多数术前使用阿片的外周动脉疾病患者在下肢旁路术后未停用阿片。
- 相当比例的术前未使用阿片患者在术后1个月仍在用阿片,术后阿片处方与持续使用关联最强。
研究设计与样本
- 回顾性分析2017年6月1日至2021年3月31日因跛行或静息痛行下肢开放旁路术的患者。
- 共纳入3873例患者,平均年龄65.7(10.2)岁,男性2650例(68.4%)。
- 按术前是否报告阿片使用分组,主要结局为出院后30天随访时持续阿片使用。
主要发现
- 913例(23.6%)术前使用阿片,其中氢可酮最常见(583例,63.9%)。
- 出院时2506例(64.7%)获得术后阿片处方;术前阿片使用者中813例(89.0%)获处方,显著高于术前未使用者的1693例(57.2%)(P < .001)。
- 术前阿片使用者的术后阿片处方量更大(24.3(21.1)片 vs 19.9(10.5)片;P < .001)。
- 30天随访时,术前阿片使用者中522例(61.3%)仍在使用阿片,术前未使用者中616例(28.4%)仍在使用(P < .001)。
- 持续阿片使用与术前阿片使用(aOR 3.23;95%CI 2.70-3.89)和获得术后阿片处方(aOR 10.83;95%CI 7.96-15.06)相关。
临床怎么用
- 针对术前使用阿片的患者,术后应主动评估停药计划并优化处方实践。
- 对术前未使用阿片的患者,也应警惕术后新发持续使用,避免不必要的阿片处方。
局限性
- 本研究为回顾性分析,可能存在未测量的混杂因素。
- 仅评估30天随访时的阿片使用,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Opioid use is common among patients with peripheral arterial disease (PAD), given that pain is a defining symptom. Unfortunately, long-term opioid use places patients at dramatically increased risk of overdose and death. Although surgical revascularization is extremely effective in alleviating ischemic pain related to PAD, it is unclear whether this practice results in the discontinuation of opioids after surgery. Therefore, we conducted the following study to investigate trends in opioid use before and after surgical bypass in patients with PAD, as well as the risk factors for continued opioid use after surgery. METHODS: We conducted a retrospective analysis of patients undergoing open lower extremity bypass for claudication or rest pain between June 1, 2017, and March 31, 2021. Patients were grouped according to whether they reported preoperative opioid use at the time of surgery. The primary outcome was continued opioid use at 30-day follow-up after discharge. A multivariable logistic regression was conducted to estimate the association of continued opioid use with patient characteristics, preoperative opioid use, and receiving a postoperative opioid prescription. RESULTS: Among 3873 patients undergoing surgery, the mean age was 65.7 (10.2) years and 2650 (68.4%) patients were male. There were 913 patients (23.6%) who used opioids preoperatively and hydrocodone was the most common preoperative opioid (583 [63.9%]). At discharge, 2506 patients (64.7%) received a postoperative opioid prescription. Postoperative opioid prescriptions were significantly more common for preoperative opioid users than opioid-naïve patients (813 [89.0%] vs 1693 [57.2%]; P < .001) and were significantly larger in size (24.3 [21.1] pills vs 19.9 [10.5] pills; P < .001). On 30-day follow-up, 522 preoperative opioid users (61.3%) and 616 opioid-naïve patients (28.4%) reported that they were still using opioids (P < .001). Continued opioid use at follow-up was associated with preoperative opioid use (adjusted odds ratio, 3.23; 95% confidence interval, 2.70-3.89) and receiving a postoperative opioid prescription (adjusted odds ratio, 10.83; 95% confidence interval, 7.96-15.06). CONCLUSIONS: Most patients with PAD who use opioids preoperatively do not discontinue opioids after lower extremity bypass. Moreover, a significant proportion of previously opioid-naïve patients are still using opioids 1 month after surgery. In both cases, postoperative opioid prescriptions had the strongest association with continued opioid use. These findings underscore the need for improved prescribing practice and increased attentiveness to discontinuation of unnecessary medications after surgery.
引用
- Howard R, Albright J, Englesbe M, et al. Opioid use in patients with peripheral arterial disease undergoing lower extremity bypass. J Vasc Surg. 2021. PMID: 34606956. doi:10.1016/j.jvs.2021.08.104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。